CompletedPhase 4

Perioperative Evaluation of Terlipressin Infusion During Living Donor Liver Transplantation on Incidence of Acute Kidney

Egypt25 participantsStarted 2013-05

Plain-language summary

To study the impact of intra and post-operative Terlipressin infusion on the occurrence of acute kidney injury after LDLT To investigate perioperative Neutrophil Gelatinase Associated Lipocalin (NGAL) changes and study the effect of Terlipressin on NGAL blood levels

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult living donor liver transplant recipients with no preoperative renal dysfunction Exclusion Criteria: * patients with renal insufficiency defined as serum creatinine \> 2 mg/dl and GFR \<60 ml/min by isotope scanning of the kidney.

What they're measuring

Development of acute kidney injury

Timeframe: 5 days postoperatuvely

Trial details

NCT IDNCT02059460

SponsorNational Liver Institute, Egypt

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-12

View on ClinicalTrials.gov More Acute Kidney Injury trials